Immune dysregulation has been implicated in Alzheimer's disease; however, precise mechanisms and timing have not been established.
Objective
To investigate the concurrent and longitudinal associations of serum C-reactive protein (CRP) and dietary inflammatory index (DII) with cognitive decline as observed in Alzheimer's disease.
Methods
The study was based on 7613 individuals who participated in Tromsø6 (2007–2008) and Tromsø7 (2015–2016). We analyzed the relationship between CRP levels, DII, and cognitive function cross-sectionally using linear regression. We used mediation analysis to examine if CRP mediates the effects of DII on cognitive function. Further, we related baseline serum CRP to cognitive function and to change in cognitive function after 7 years of follow up. We used linear mixed models to relate changes in CRP levels to changes in cognitive function measured at two time points with 7 years apart.
Results
Both CRP level and DII were cross-sectionally inversely associated with cognitive function (psychomotor speed, executive function). There was no prospective relationship between CRP level at baseline and cognitive function after 7 years of follow up. Increase in CRP levels was associated with decrease in cognitive function (psychomotor speed, executive function, and verbal memory) observed between two measurements 7 years apart. The mediation model did not show convincing evidence of a mediating effect of CRP in the association between diet and cognitive function.
Conclusions
After comprehensive analysis of associations between CRP, DII and cognitive function, we conclude that CRP is likely to reflect the changes in inflammatory environment occurring in parallel with cognitive decline.
Tahami MonfaredAAByrnesMJWhiteLA, et al.Alzheimer's disease: epidemiology and clinical progression. Neurol Ther2022; 11: 553–569.
2.
MasonAHolmesCEdwardsCJ. Inflammation and dementia: using rheumatoid arthritis as a model to develop treatments?Autoimmun Rev2018; 17: 919–925.
3.
BettcherBMTanseyMGDorotheeG, et al.Peripheral and central immune system crosstalk in Alzheimer disease - a research prospectus. Nat Rev Neurol2021; 17: 689–701.
4.
TejeraDMercanDSanchez-CaroJM, et al.Systemic inflammation impairs microglial Abeta clearance through NLRP3 inflammasome. EMBO J2019; 38: e101064.
5.
OzbenTOzbenS. Neuro-inflammation and anti-inflammatory treatment options for Alzheimer's disease. Clin Biochem2019; 72: 87–89.
6.
AvgerinosKIFerrucciLKapogiannisD. Effects of monoclonal antibodies against amyloid-beta on clinical and biomarker outcomes and adverse event risks: a systematic review and meta-analysis of phase III RCTs in Alzheimer's disease. Ageing Res Rev2021; 68: 101339.
7.
YaoZZhangYWuH. Regulation of C-reactive protein conformation in inflammation. Inflamm Res2019; 68: 815–823.
8.
JiaJNingYChenM, et al.Biomarker changes during 20 years preceding Alzheimer's disease. N Engl J Med2024; 390: 712–722.
9.
NobleJMManlyJJSchupfN, et al.Association of C-reactive protein with cognitive impairment. Arch Neurol2010; 67: 87–92.
10.
Singh-ManouxADugravotABrunnerE, et al.Interleukin-6 and C-reactive protein as predictors of cognitive decline in late midlife. Neurology2014; 83: 486–493.
11.
WalkerKAGottesmanRFWuA, et al.Systemic inflammation during midlife and cognitive change over 20 years: the ARIC Study. Neurology2019; 92: e1256–e1267.
12.
YaffeKKanayaALindquistK, et al.The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA2004; 292: 2237–2242.
13.
LimaTAAdlerALMinettT, et al.C-reactive protein, APOE genotype and longitudinal cognitive change in an older population. Age Ageing2014; 43: 289–292.
14.
ShivappaNSteckSEHurleyTG, et al.Designing and developing a literature-derived, population-based dietary inflammatory index. Public Health Nutr2014; 17: 1689–1696.
15.
TangneyCCLiHWangY, et al.Relation of DASH- and Mediterranean-like dietary patterns to cognitive decline in older persons. Neurology2014; 83: 1410–1416.
16.
MorrisMCTangneyCCWangY, et al.O2-02-04: mind diet score more predictive than dash or Mediterranean diet scores. Alzheimers Dement2014; 10: P166–P166.
17.
TangneyCLiHBarnesLL, et al.Accordance to dietary approaches to stop hypertension (DASH) is associated with slower cognitive decline. Alzheimers Dement2013; 9: P135.
18.
van den BrinkACBrouwer-BrolsmaEMBerendsenAAM, et al.The Mediterranean, Dietary Approaches to Stop Hypertension (DASH), and Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diets are associated with less cognitive decline and a lower risk of Alzheimer's disease-A review. Adv Nutr2019; 10: 1040–1065.
19.
EllouzeIShefflerJNagpalR, et al.Dietary patterns and Alzheimer's disease: an updated review linking nutrition to neuroscience. Nutrients2023; 15: 3204.
20.
LiuXMorrisMCDhanaK, et al.Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) study: rationale, design and baseline characteristics of a randomized control trial of the MIND diet on cognitive decline. Contemp Clin Trials2021; 102: 106270.
21.
LeblhuberFEhrlichDSteinerK, et al.The immunopathogenesis of Alzheimer's disease is related to the composition of gut microbiota. Nutrients2021; 13: 361.
EggenAEMathiesenEBWilsgaardT, et al.The sixth survey of the Tromsø Study (Tromsø 6) in 2007–08: collaborative research in the interface between clinical medicine and epidemiology: study objectives, design, data collection procedures, and attendance in a multipurpose population-based health survey. Scand J Public Health2013; 41: 65–80.
24.
HopstockLAGrimsgaardSJohansenH, et al.The seventh survey of the Tromsø Study (Tromsø7) 2015–2016: study design, data collection, attendance, and prevalence of risk factors and disease in a multipurpose population-based health survey. Scand J Public Health2022; 50: 919–929.
25.
LundbladMWAndersenLFJacobsenBK, et al.Energy and nutrient intakes in relation to National Nutrition Recommendations in a Norwegian population-based sample: the Tromso Study 2015–16. Food Nutr Res2019; 63. doi: https://doi.org/10.29219/fnr.v63.3616
26.
TombaughTNMcIntyreNJ. The mini-mental state examination: a comprehensive review. J Am Geriatr Soc1992; 40: 922–935.
27.
PalmerKBäckmanLWinbladB, et al.Detection of Alzheimer's disease and dementia in the preclinical phase: population based cohort study. BMJ2003; 326: 245.
28.
LezakMDHowiesonDBLoringDW, et al.Neuropsychological assessment. New York: Oxford University Press, 2004.
29.
BenjaminiYHochbergY. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B Methodol2018; 57: 289–300.
30.
LangeTVansteelandtSBekaertM. A simple unified approach for estimating natural direct and indirect effects. Am J Epidemiol2012; 176: 190–195.
31.
ZivkovicSMaricGCvetinovicN, et al.Anti-inflammatory effects of lipid-lowering drugs and supplements-A narrative review. Nutrients2023; 15: 1517.
32.
Kendel JovanovicGMrakovcic-SuticIPavicic ZezeljS, et al.The efficacy of an energy-restricted anti-inflammatory diet for the management of obesity in younger adults. Nutrients2020; 12: 3583.
33.
HariharanROdjidjaENScottD, et al.The dietary inflammatory index, obesity, type 2 diabetes, and cardiovascular risk factors and diseases. Obes Rev2022; 23: e13349.
34.
RossiAMikailNBengsS, et al.Heart-brain interactions in cardiac and brain diseases: why sex matters. Eur Heart J2022; 43: 3971–3980.
35.
LevitzkyYSGuoC-YRongJ, et al.Relation of smoking status to a panel of inflammatory markers: the framingham offspring. Atherosclerosis2008; 201: 217–224.
36.
FrostCThompsonSG. Correcting for regression dilution bias: comparison of methods for a single predictor variable. J R Stat Soc Ser A Stat Soc2000; 163: 173–189.
37.
TwiskJWR. Indirect effects in mediation analyses should not be tested for statistical significance. J Clin Epidemiol2024; 171: 111393.
38.
LongSChenYMengY, et al.Peripheral high levels of CRP predict progression from normal cognition to dementia: a systematic review and meta-analysis. J Clin Neurosci2023; 107: 54–63.
39.
KorczynADGrinbergLT. Is Alzheimer disease a disease?Nat Rev Neurol2024; 20: 245–251.
40.
RutterCEMillardLACBorgesMC, et al.Exploring regression dilution bias using repeat measurements of 2858 variables in </=49,000 UK biobank participants. Int J Epidemiol2023; 52: 1545–1556.
41.
LewisNAKnightJE. Longitudinal associations between C-reactive protein and cognitive performance in normative cognitive ageing and dementia. Age Ageing2021; 50: 2199–2205.
42.
FranceschiCBonafeMValensinS, et al.Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci2000; 908: 244–254.
43.
SaliveME. Multimorbidity in older adults. Epidemiol Rev2013; 35: 75–83.
44.
TamBTMoraisJASantosaS. Obesity and ageing: two sides of the same coin. Obes Rev2020; 21: e12991.
45.
StevensonAJMcCartneyDLHillaryRF, et al.Characterisation of an inflammation-related epigenetic score and its association with cognitive ability. Clin Epigenetics2020; 12: 113.
46.
LassaleCBattyGDSteptoeA, et al.Association of 10-year C-reactive protein trajectories with markers of healthy aging: findings from the English longitudinal study of aging. J Gerontol A Biol Sci Med Sci2019; 74: 195–203.
47.
JennyNSFrenchBArnoldAM, et al.Long-term assessment of inflammation and healthy aging in late life: the cardiovascular health study all stars. J Gerontol A Biol Sci Med Sci2012; 67: 970–976.
48.
WichmannMACruickshanksKJCarlssonCM, et al.Long-term systemic inflammation and cognitive impairment in a population-based cohort. J Am Geriatr Soc2014; 62: 1683–1691.
49.
MorrisMC. Nutritional determinants of cognitive aging and dementia. Proc Nutr Soc2012; 71: 1–13.
50.
ScarmeasNSternYTangMX, et al.Mediterranean Diet and risk for Alzheimer's disease. Ann Neurol2006; 59: 912–921.
51.
ScarmeasNSternYMayeuxR, et al.Mediterranean Diet and mild cognitive impairment. Arch Neurol2009; 66: 216–225.
52.
MorrisMCEvansDATangneyCC, et al.Associations of vegetable and fruit consumption with age-related cognitive change. Neurology2006; 67: 1370–1376.
53.
SacksFMAppelLJMooreTJ, et al.A dietary approach to prevent hypertension: a review of the Dietary Approaches to Stop Hypertension (DASH) study. Clin Cardiol1999; 22: III6–II10.
54.
MorrisMCTangneyCCWangY, et al.MIND Diet slows cognitive decline with aging. Alzheimers Dement2015; 11: 1015–1022.
55.
MorrisMCTangneyCCWangY, et al.MIND Diet associated with reduced incidence of Alzheimer's disease. Alzheimers Dement2015; 11: 1007–1014.
56.
HoskingDEEramudugollaRCherbuinN, et al.MIND Not Mediterranean diet related to 12-year incidence of cognitive impairment in an Australian longitudinal cohort study. Alzheimers Dement2019; 15: 581–589.
57.
DevoreEEKangJHBretelerMM, et al.Dietary intakes of berries and flavonoids in relation to cognitive decline. Ann Neurol2012; 72: 135–143.
58.
SchaeferEJBongardVBeiserAS, et al.Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study. Arch Neurol2006; 63: 1545–1550.
59.
CharisisSNtanasiEYannakouliaM, et al.Diet inflammatory Index and dementia incidence: a population-based study. Neurology2021; 97: e2381–e2391.
60.
ShiYLinFLiY, et al.Association of pro-inflammatory diet with increased risk of all-cause dementia and Alzheimer's dementia: a prospective study of 166,377 UK biobank participants. BMC Med2023; 21: 266.
61.
PengMYuanSLuD, et al.Dietary inflammatory index, genetic susceptibility and risk of incident dementia: a prospective cohort study from UK biobank. J Neurol2024; 271: 1286–1296.
62.
SongWFengYGongZ, et al.The association between dietary inflammatory Index and cognitive performance in older adults aged 60 years and older. Front Nutr2022; 9: 748000.
63.
FrithEShivappaNMannJR, et al.Dietary inflammatory index and memory function: population-based national sample of elderly Americans. Br J Nutr2018; 119: 552–558.
64.
DugganMRButlerLPengZ, et al.Plasma proteins related to inflammatory diet predict future cognitive impairment. Mol Psychiatry2023; 28: 1599–1609.
65.
KipnisVSubarAFMidthuneD, et al.Structure of dietary measurement error: results of the OPEN biomarker study. Am J Epidemiol2003; 158: 14–21. discussion 22-16.
66.
GiudiceDGangestadMWS. Rethinking IL-6 and CRP: why they are more than inflammatory biomarkers, and why it matters. Brain Behav Immun2018; 70: 61–75.
67.
IakunchykovaOPanMAmlienIK, et al.Genetic evidence for the causal effects of C-reactive protein on self-reported habitual sleep duration. Brain Behav Immun Health2024; 37: 100754.
68.
IakunchykovaOBenrosMEWangY. Author reply–Letter to the Editor “elevated C-reactive protein and IL-6 signalling are not the only determinants of sleep quality and duration”. Brain Behav Immun Health2024; 39: 100785.
69.
PalsetiaDRaoGPTiwariSC, et al.The clock drawing test versus Mini-mental status examination as a screening tool for dementia: a clinical comparison. Indian J Psychol Med2018; 40: 1–10.
70.
VertesiALeverJAMolloyDW, et al.Standardized mini-mental state examination. Use and interpretation. Can Fam Physician2001; 47: 2018–2023.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
